The strength of our study is that we were able to confirm that - based on a biomarker signal of elevated sputum eosinophils - a reduction in airway eosinophilia can be achieved by the GATA3-specific DNAzyme similar to the reduction observed in in asthma patients before [21, 22]. This evidence concerns the gene GATA3 and asthma.